FDA Pressure Likely In Novartis OTC Plant Shutdown, Recalls
By
Dan Schiff / Email the Author / “The Tan Sheet” Feb. 6, 2012, Vol. 20, No. 06
Regulatory / Word Count: 854 / Article # 05120206007
Executive Summary
FDA inspectors were in Novartis Consumer Health’s Lincoln, Neb., plant in December and January, as the company was deciding to halt production and recall products. An inspection report notes 10 observations – eight of them repeats from FDA’s visit in mid-2011.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.